Related references
Note: Only part of the references are listed.Purinergic receptors: new targets for the treatment of gout and fibrosis
Thomas Gicquel et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis
Oliver John Kennedy et al.
BMJ OPEN (2017)
Coffee Consumption and Prevention of Cirrhosis: In Support of the Caffeine Hypothesis
Jonathan A. Dranoff
GENE EXPRESSION (2017)
Coffee Consumption and the Risk of Colorectal Cancer
Stephanie L. Schmit et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis
Giuseppe Grosso et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)
Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration
Patrycja Koszalka et al.
PLOS ONE (2016)
Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer
Ruoyu Miao et al.
SCIENTIFIC REPORTS (2016)
Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor
Hadar Eini et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project
Jessica L. Petrick et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Coffee and Liver Health
Filomena Morisco et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
CD39 and CD161 Modulate Th17 Responses in Crohn's Disease
Aiping Bai et al.
JOURNAL OF IMMUNOLOGY (2014)
Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma
Z. Gordon Jiang et al.
PURINERGIC SIGNALLING (2014)
Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980
C. Bosetti et al.
ANNALS OF ONCOLOGY (2013)
Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/Entpd1 null Mice
Xiaofeng Sun et al.
HEPATOLOGY (2013)
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
A novel fused 1,2,4-triazine aryl derivative as antioxidant and nonselective antagonist of adenosine A2A receptors in ethanol-activated liver stellate cells
Agnieszka Szuster-Ciesielska et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2012)
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery
Rodolphe Anty et al.
JOURNAL OF HEPATOLOGY (2012)
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
Pierre-Alain Clavien et al.
LANCET ONCOLOGY (2012)
Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case-Control Study
Dimitrios Trichopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Vascular CD39/ENTPD1 Directly Promotes Tumor Cell Growth by Scavenging Extracellular Adenosine Triphosphate
Lili Feng et al.
NEOPLASIA (2011)
CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
Xiaofeng Sun et al.
GASTROENTEROLOGY (2010)
Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma
Marco Vivarelli et al.
TRANSPLANTATION (2010)
Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection
Shu-Chun Chuang et al.
CANCER LETTERS (2009)
Coffee Drinking and Hepatocellular Carcinoma: An Update
Francesca Bravi et al.
HEPATOLOGY (2009)
Impact of Sirolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Srinath Chinnakotla et al.
LIVER TRANSPLANTATION (2009)
Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: Implications for surveillance studies and new adjuvant therapies
Edie Y. Chan et al.
LIVER TRANSPLANTATION (2008)
Liver transplantation for hepatocellular carcinoma:: University hospital Essen experience and metaanalysis of prognostic factors
Georgios C. Sotiropoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Primary hepatocellular cancer in the explanted liver: Outcome of transplantation and risk factors for HCC recurrence
L. A. Kondili et al.
EJSO (2007)
Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan
Keitaro Tanaka et al.
CANCER SCIENCE (2007)
Polyoxometalates -: a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors
Christa E. Mueller et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study
Satoko Ohfuji et al.
HEPATOLOGY RESEARCH (2006)
Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity
C Cavin et al.
FOOD AND CHEMICAL TOXICOLOGY (2002)